top of page
POSTBIOTICS
IMG_6791.PNG
  • Our proprietary postbiotic, developed from Lactobacillus species, demonstrates potent inhibitory activity against high-burden pathogens including Escherichia coli, Streptococcus mutans, and Helicobacter pylori. By harnessing microbiome modulation and bioactive metabolite pathways, it delivers clinically validated benefits across gut health, oral care, and dermatological applications—positioning it as a next-generation innovation at the convergence of biotechnology and global health.
  • Postbiotics are defined as bioactive compounds generated during the metabolic activity of probiotic bacteria when fermenting prebiotic substrates such as dietary fibers. These compounds include short-chain fatty acids, lipopolysaccharides, exopolysaccharides, enzymes, bacterial lysates, cell wall fragments, cell-free supernatants, and essential metabolites such as vitamins and amino acids. Collectively, these components contribute to immune modulation, pathogen inhibition, intestinal barrier integrity, and overall host well-being.
image.png
image.png
L rhamnosus postbiotic Anti-microbial test against e coli
L rhamnosus postbiotic Anti-microbial test against S aureus
bottom of page